1. Xu XR, Liu CQ, Feng BS, Liu ZJ. Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease. World J Gastroenterol. 2014; 20:3255–3264.
Article
2. Ooi CJ, Hilmi I, Banerjee R, et al. Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia. J Gastroenterol Hepatol. 2019; 34:1296–1315.
Article
3. Kucharzik T, Ellul P, Greuter T, et al. ECCO Guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease. J Crohns Colitis. 2021; 15:879–913.
Article
4. Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG Clinical Guideline: preventive care in inflammatory bowel dis ease. Am J Gastroenterol. 2017; 112:241–258.
5. Barberio B, Savarino EV, Card T, et al. Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluation. Intest Res. 2022; 20:114–123.
Article
6. Lee YJ, Kim SE, Park YE, et al. SARS-CoV-2 vaccination for adult patients with inflammatory bowel disease: expert consensus statement by KASID. Intest Res. 2022; 20:171–183.
Article
7. Mishra A, Puri AS, Sachdeva S, Dalal A. Efficacy of hepatitis B vaccination in patients with ulcerative colitis: a prospective cohort study. Intest Res. 2022; 20:445–451.
Article
8. Gurvits GE, Lan G, Tan A, Weissman A. Vaccination practices in patients with inflammatory bowel disease among general internal medicine physicians in the USA. Postgrad Med J. 2017; 93:333–337.
Article
9. Jung YS, Park JH, Kim HJ, et al. Insufficient knowledge of Korean gastroenterologists regarding the vaccination of patients with inflammatory bowel disease. Gut Liver. 2014; 8:242–247.
Article
10. Park SB, Kim KO, Lee HS, et al. Vaccination in patients with inflammatory bowel disease-Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting. Intest Res. 2023; 21:363–374.